Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Pharmacol Res. 2017 Apr 8;120:252–257. doi: 10.1016/j.phrs.2017.04.005

Figure 2. Anti-CD3 therapy attenuates autoantibody production in SLE mice.

Figure 2

Circulating anti-dsDNA autoantibodies (presented as antibody activity index) measured in control and SLE mice administered anti-IgG or anti-CD3 (n = 3–12).